2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
211
Triple Negative Breast Neoplasms
32
Stomach Neoplasms
32
Inflammatory Breast Neoplasms
21
Esophageal Neoplasms
16
Carcinoma, Hepatocellular
15
Lymphoma, Large B-Cell, Diffuse
9
Sarcoma
8
Neoplasms
8
Non-Muscle Invasive Bladder Neoplasms
6
Urinary Bladder Neoplasms
5
Pancreatic Neoplasms
5
Liver Neoplasms
5
Breast Neoplasms, Male
5
Adenocarcinoma Of Esophagus
5
Ovarian Neoplasms
4
Lymphoma
4
Testicular Neoplasms
3
Primary Breast Cancer
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pathologic Complete Response
3
Hemangiosarcoma
3
Gallbladder Neoplasms
3
Carcinoma, Ductal, Breast
3
Unspecified Adult Solid Tumor, Protocol Specific
2
Recurrence
2
Prostatic Neoplasms
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neoplastic Cells, Circulating
2
Interventions
Letrozole
6
Radiotherapy
4
Carboplatin
4
atamestane
3
Trastuzumab
3
Toremifene
3
Magnetic Resonance Spectroscopy
3
Fulvestrant
3
Docetaxel
3
Cyclophosphamide
3
Chemotherapy, Adjuvant
3
Tamoxifen
2
Paclitaxel
2
Gene Expression Profiling
2
Estrogen Receptor Modulators
2
Capecitabine
2
Aromatase Inhibitors
2
Amplified Fragment Length Polymorphism Analysis
2
repotrectinib
1
proto-oncogene protein c-fes-fps
1
palbociclib
1
neratinib
1
gallium 68 PSMA-11
1
fluciclovine F-18
1
entrectinib
1
Zolpidem
1
Vorinostat
1
Vinorelbine
1
Venlafaxine Hydrochloride
1
Thiotepa
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma, Lobular
×
Epirubicin
×
Clear all
NCT01641406
2012-07-16
NACprotocol
Auxilio Mutuo Cancer Center
Phase 2
Unknown
60 enrolled